Table 2 Tumor types.
Tumor type* | No. of patients, Part A (%) | No. of patients, Part B (%) | Total no. of patients (%) |
|---|---|---|---|
(N = 391) | (N = 209) | (N = 600) | |
GI, other (non-CRC) | 65 (16.6) | 43 (20.6) | 108 (18.0) |
Head and neck | 68 (17.4) | 20 (9.6) | 88 (14.7) |
CRC | 35 (9.0) | 38 (18.2) | 73 (12.2) |
Lung | 48 (12.3) | 12 (5.7) | 60 (10) |
Breast | 31 (7.9) | 21 (10) | 52 (8.7) |
Sarcoma | 33 (8.4) | 17 (8.1) | 50 (8.3) |
GYN, other (non-ovarian) | 30 (7.7) | 12 (5.7) | 42 (7) |
Prostate | 15 (3.8) | 16 (7.7) | 31 (5.2) |
Ovarian | 20 (5.1) | 6 (2.9) | 26 (4.3) |
GU, other (non-prostate) | 23 (5.9) | 0 | 23 (3.8) |
Melanoma | 8 (2.0) | 12 (5.7) | 20 (3.3) |
Endocrine | 12 (3.1) | 4 (1.9) | 16 (2.7) |
Other cancers | 0 | 7 (3.3) | 7 (1.2) |
CUP | 3 (0.8) | 1 (0.5) | 4 (0.7) |
